Beschreibung
Alprazolam and gabapentin produce additive CNS depression, increasing the risk of sedation, dizziness, and psychomotor impairment.
Mechanismus
GABA-A potentiation (alprazolam) combined with alpha-2-delta calcium channel modulation and GABAergic enhancement (gabapentin) produces additive CNS inhibition.
Klinische Bedeutung
Excessive sedation and ataxia are common with this combination; fall and fracture risk is substantially elevated.
Maßnahmen
Use caution; reduce doses of both agents and advise against activities requiring alertness until tolerance to sedation is established.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.